Jinyu Medical (603882.SH): Initial repurchase of 45,000 shares

Gelonghui, April 16, 丨 Jinyu Medical (603882.SH) announced that on April 16, 2024, the company implemented the first repurchase of the company's shares through the Shanghai Stock Exchange trading system. The company repurchased a total of 45,000 shares for the first time through centralized bidding transactions, accounting for 0.0096% of the company's current total share capital. The highest price of the repurchase transaction was 46.97 yuan/share, and the lowest price was 46.24 yuan/share. The total amount paid was RMB 2,09728.00 (excluding transaction fees and other fees).

Gelonghui FinanceApr 16 05:24 ET

Jinyu Medical (603882.SH): Chairman proposes to buy back the company's shares

On April 9, Ge Longhui Medical (603882.SH) announced that Mr. Leung Yiu-ming, the controlling shareholder, actual controller and chairman of the company, is based on confidence in the company's continuous development and high recognition of the company's value. In order to more effectively integrate shareholders' interests, company interests and employees' personal interests to promote the long-term, stable and sustainable development of the company, Mr. Leung Yiu-ming proposed that the company use its own funds to repurchase the company's shares through centralized bidding transactions to implement equity incentives. Total capital to be repurchased: RMB 50 million.

Gelonghui FinanceApr 9 05:06 ET

Zhitong A Share Sale Restriction and Release List | April 9

According to the Zhitong Finance App, the ban on restricted shares of 7 listed companies was lifted on April 9, with a total market value of about 5.471 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, number of shares unbanned, Huabei Pharmaceutical 600812 issued additional A shares, the original shareholder placed 84.256 million shares before issuance, limited sale and circulation 102 million, Jinyu Medical 603882, the original shareholders placed 3.1237 million additional A shares, the original shareholder placed and listed 3.1237 million Yingqu Technology 002925 share incentives to limit circulation 254,200 CCC Radiation 300962 shares restricted circulation before issuance 1.4

Zhitong FinanceApr 8 21:00 ET

Declining Stock and Solid Fundamentals: Is The Market Wrong About Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)?

Guangzhou Kingmed Diagnostics Group (SHSE:603882) has had a rough month with its share price down 6.7%. However, stock prices are usually driven by a company's financial performance over the long te

Simply Wall StApr 4 20:01 ET

Jinyu Medical (603882.SH) has spent 84.748,900 yuan to buy back 1.496 million shares

Jinyu Medical (603882.SH) issued an announcement. As of March 31, 2024, the repurchase plan company...

Zhitong FinanceApr 1 05:06 ET

Guoxin Securities: The pharmaceutical industry is entering an upward inflection point in the medium to long term, and focus on high growth targets in the quarterly report in the short term

The pharmaceutical industry currently has low growth, low profitability, undervaluation, and low transaction attention, and is entering a major layout range at an upward inflection point in the medium to long term.

Zhitong FinanceMar 28 02:48 ET